EUVIMEDEUVIMED entdecken
Crossref

Afectación gastrointestinal objetiva en los pacientes con esclerosis sistémica: prevalencia y fenotipos clínico-inmunológicos en el registro REMSCLE

Alberto Ezquerra-Durán, Alfredo Guillen-Del-Castillo, Francisco Alejandro Felix Tellez, Ana Argibay-Filgueira, Begoña Marí-Alfonso, Mayka Freire, Luis G Alcalá-González, Carmen P Simeón-Aznar, e investigadores del registro REMSCLE de la Sociedad Española Multidisciplinar de Enfermedades Autoinmunes (SEMAIS)

Medicina Clínica · 2026-04 · 166 (4) · 107374

DOI: 10.1016/j.medcli.2026.107374 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Medicina Clínica, 2026-04. Verfasst von Alberto Ezquerra-Durán und 8 weiteren Autor:innen. Beteiligte Einrichtung: Neurogastroenterology and Motility Unit, Gastroenterology Department, Institut Clínic de Malalties Digestives i Metabòliques (ICMDM), Hospital Clinic…. Hauptthemen laut MEDLINE: Scleroderma, Systemic, Gastrointestinal Diseases. Die Arbeit nennt 32 Literaturangaben. Gefördert von: Carlos III Health Institute, Universidad Autónoma de Madrid.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

INTRODUCTION Gastrointestinal (GI) involvement is the most frequent visceral manifestation of systemic sclerosis (SSc) and is associated with increased morbidity and mortality. To date, its characterization using specific diagnostic tests has been poorly described in the Spanish population. METHODS A cross-sectional study was conducted including patients with SSc enrolled in the Spanish Multidisciplinary Scleroderma Registry (REMSCLE) up to April 2024 who had undergone at least one GI diagnostic test. Objective GI involvement was defined as the presence of pathological findings in any of these tests. Clinical, immunological, and functional characteristics were compared between patients with and without objective GI involvement. RESULTS A total of 816 patients were included, of whom 492 (60.3%) presented objective GI involvement, with esophageal dysmotility being the most frequent finding (77.3%). GI involvement was associated with an earlier disease onset (46.2 vs. 50.7 years; P=.002), a higher prevalence of the diffuse subtype (23.2% vs. 14.8%; P=.003), and more vascular manifestations, including digital ulcers (42.8% vs. 34.7%; P=.021), telangiectasias (72.0% vs. 63.0%; P=.008), and non-inflammatory myopathy (11.3% vs. 4.4%; P=.015). Patients with GI involvement also showed a higher prevalence of interstitial lung disease (51.4% vs. 39.2%; P=.001) and cardiac involvement (41.3% vs. 28.0%; P

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Scleroderma, SystemicGastrointestinal DiseasesHumansFemaleCross-Sectional StudiesRegistriesMiddle AgedMalePrevalencePhenotypeSpainAdultAgedEsophageal Motility DisordersTelangiectasisAntibodies, Antinuclear

Stichwörter der Autor:innen

Afectación gastrointestinalDismotilidad gastrointestinalEsclerosis sistémicaGastrointestinal dysmotilityGastrointestinal involvementSystemic sclerosis

Substanzen

Antibodies, Antinuclear

Autor:innen und Institutionen

  • Neurogastroenterology and Motility Unit, Gastroenterology Department, Institut Clínic de Malalties Digestives i Metabòliques (ICMDM), Hospital Clinic of Barcelona, University of Barcelona, Barcelona, Spain. Electronic a…
  • Systemic Autoimmune Diseases Unit, Internal Medicine Department, Vall d'Hebron University Hospital, Barcelona, Spain.
  • Digestive System Research Unit, Department of Digestive Diseases, Vall d'Hebron University Hospital, Barcelona, Spain.
  • Unit of Systemic Autoimmune Diseases and Thrombosis, Department of Internal Medicine, Complejo Hospitalario Universitario de Vigo, Vigo, Pontevedra, Spain.
  • Department of Internal Medicine, Hospital Universitari Parc Taulí, Sabadell, Barcelona, Spain.
  • Unit of Autoimmune Diseases, Department of Internal Medicine, Hospital Clínico Universitario de Santiago, Santiago de Compostela, A Coruña, Spain.

Förderung

  • Carlos III Health Institute
  • Universidad Autónoma de Madrid

Zitieren

APA

Ezquerra-Durán, A., Guillen-Del-Castillo, A., Felix Tellez, F. A., Argibay-Filgueira, A., Marí-Alfonso, B., Freire, M., Alcalá-González, L. G., Simeón-Aznar, C. P., & e investigadores del registro REMSCLE de la Sociedad Española Multidisciplinar de Enfermedades Autoinmunes (SEMAIS) (2026). Afectación gastrointestinal objetiva en los pacientes con esclerosis sistémica: prevalencia y fenotipos clínico-inmunológicos en el registro REMSCLE. Medicina Clínica, 166(4), 107374. https://doi.org/10.1016/j.medcli.2026.107374

Vancouver

Ezquerra-Durán A, Guillen-Del-Castillo A, Felix Tellez FA, Argibay-Filgueira A, Marí-Alfonso B, Freire M, et al. Afectación gastrointestinal objetiva en los pacientes con esclerosis sistémica: prevalencia y fenotipos clínico-inmunológicos en el registro REMSCLE. Medicina Clínica. 2026;166(4):107374. doi:10.1016/j.medcli.2026.107374

BibTeX
@article{EzquerraDurn2026,
  author = {Ezquerra-Durán, Alberto and Guillen-Del-Castillo, Alfredo and Felix Tellez, Francisco Alejandro and Argibay-Filgueira, Ana and Marí-Alfonso, Begoña and Freire, Mayka and Alcalá-González, Luis G and Simeón-Aznar, Carmen P and e investigadores del registro REMSCLE de la Sociedad Española Multidisciplinar de Enfermedades Autoinmunes (SEMAIS), e investigadores del registro REMSCLE de la Sociedad Española Multidisciplinar de Enfermedades Autoinmunes (SEMAIS)},
  title = {Afectación gastrointestinal objetiva en los pacientes con esclerosis sistémica: prevalencia y fenotipos clínico-inmunológicos en el registro REMSCLE},
  journal = {Medicina Clínica},
  year = {2026},
  volume = {166},
  number = {4},
  pages = {107374},
  doi = {10.1016/j.medcli.2026.107374}
}
Kostenlos starten →